# Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

> **NCT03680898** · NA · UNKNOWN · sponsor: **Meridian Bioscience, Inc.** · enrollment: 1200 (estimated)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae

## Interventions

- **DEVICE:** Rectal swab collection

## Key facts

- **NCT ID:** NCT03680898
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-12
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680898, "Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03680898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*